Gitar
Builds AI agents for code review and continuous integration workflows
$9MUndisclosed
Role not disclosedActivity from announced rounds
Venrock is the venture manager whose own Encoded portfolio identifies investor Bryan Roberts.
Encoded develops neurological gene therapies. Other recorded companies include Gitar’s software-review agents and Adcendo’s targeted cancer medicines. Venrock Healthcare Capital Partners remains a separate manager identity.
Builds AI agents for code review and continuous integration workflows
Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.